InsidersTradesSigma
Total declarations
Company
▲ Purchases (27 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
27
Disclosed sells
4
T+90 hit rate
0%
T+90 mean return
-56.7%
Across 24 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Cambrian BioPharma Inc, Chief Executive Officer. Officer active across 1 company, notably Sensei Biotherapeutics, Inc.. Aggregated, 35 filings have been recorded. Breakdown: 27 buys · 4 sells. Total volume traded: €1.8m. History available since 5 May 2021. The latest transaction was filed on 1 June 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Cambrian BioPharma Inc
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations35 total
24,524 shares@ US$20.001.96% mcap9.2% of flowCommon StockSEC:0000897069-26-001299:0
476 shares@ US$21.140.040% mcap0.2% of flowCommon StockSEC:0000897069-26-001299:1
3,105 shares@ US$8.590.6% of flowCommon StockSEC:0000897069-25-001795:0
5,000 shares@ US$9.061.1% of flowCommon StockSEC:0000897069-25-001776:0
1,587,302 shares@ US$1.2639.8% of flowCommon StockSEC:0000897069-23-001054:0
4,466 shares0Common StockSEC:0001209191-23-042076:0
4,466 shares0Restricted Stock Unit GrantSEC:0001567619-23-004608:0
4,466 shares0Restricted Stock Unit GrantSEC:0001567619-22-012842:0
1,203 shares@ US$3.200.013% mcap0.1% of flowCommon StockSEC:0001567619-22-012646:0
Canonical exit: 31 May 2022 (T+90)
9,500 shares@ US$14.340.42% mcap4.9% of flowCommon StockSEC:0001567619-22-008800:0
Canonical exit: 21 Jun 2021 (T+90)
752 shares@ US$19.750.045% mcap0.5% of flowCommon StockSEC:0001567619-22-008798:0
Canonical exit: 19 May 2021 (T+90)
1,203 shares@ US$3.200.013% mcap0.1% of flowCommon StockSEC:0001567619-22-006007:0
Canonical exit: 31 May 2022 (T+90)
42 shares@ US$3.600.0005% mcap0.0% of flowCommon StockSEC:0001567619-22-005913:0
Canonical exit: 29 May 2022 (T+90)
2,500 shares@ US$3.650.030% mcap0.4% of flowCommon StockSEC:0001567619-22-005791:0
Canonical exit: 26 May 2022 (T+90)
2,500 shares@ US$3.800.031% mcap0.4% of flowCommon StockSEC:0001567619-22-005518:0
Canonical exit: 24 May 2022 (T+90)
4,949 shares@ US$4.170.066% mcap0.8% of flowCommon StockSEC:0001567619-22-005190:0
Canonical exit: 18 May 2022 (T+90)
10,000 shares@ US$4.180.13% mcap1.6% of flowCommon StockSEC:0001567619-22-004779:0
Canonical exit: 15 May 2022 (T+90)
5,000 shares@ US$4.580.073% mcap0.9% of flowCommon StockSEC:0001567619-22-004543:0
Canonical exit: 11 May 2022 (T+90)
17,500 shares@ US$4.650.26% mcap3.1% of flowCommon StockSEC:0001567619-22-002937:0
Canonical exit: 4 May 2022 (T+90)
6,100 shares@ US$4.310.085% mcap1.0% of flowCommon StockSEC:0001567619-22-002036:0
Canonical exit: 27 Apr 2022 (T+90)
20,100 shares@ US$4.860.31% mcap3.7% of flowCommon StockSEC:0001567619-22-001801:0
Canonical exit: 25 Apr 2022 (T+90)
24,703 shares@ US$4.940.39% mcap4.7% of flowCommon StockSEC:0001567619-22-001632:0
Canonical exit: 21 Apr 2022 (T+90)
10,244 shares@ US$4.970.16% mcap1.9% of flowCommon StockSEC:0001567619-22-001462:0
Canonical exit: 19 Apr 2022 (T+90)
10,000 shares@ US$5.080.16% mcap1.9% of flowCommon StockSEC:0001567619-22-001340:0
Canonical exit: 18 Apr 2022 (T+90)
19,953 shares@ US$5.130.33% mcap3.9% of flowCommon StockSEC:0001567619-22-001228:0
Canonical exit: 13 Apr 2022 (T+90)
25 of 35 declarations
About Cambrian BioPharma Inc
Cambrian BioPharma Inc is a Chief Executive Officer and has 35 filings in total. Across the 35 sampled filings, they cover the period from 2021-05-06 to 2026-06-01, with buys totaling EUR 1274071 and sells totaling EUR 2311287, and the most frequent transaction nature is Acquisition. The filings relate to Sensei Biotherapeutics, Inc., where they are a 10% Owner, and the largest published filings include a sell of EUR 1818580.556963321 on 2023-08-02, a sell of EUR 422303.2988280861 on 2026-06-01, and buys of EUR 303691.3550080424 on 2021-12-30, EUR 114162.1094105264 on 2022-04-21, EUR 107862.3677030985 on 2022-01-25, and EUR 89461.66666060148 on 2022-01-18.
